Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor [EPC] - N0000194142

Pharmacologic Code	N0000194142
Pharmacologic Name	Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor
Pharmacologic Uses	triazaacenaphthylene bacterial type II topoisomerase inhibitor
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0173-0922	Blujepa	Non-Proprietary Name: Gepotidacin	Tablet, Film Coated	Oral	Glaxosmithkline Llc	ACTIVE